Pulse.

a daily field guide to health research that matters

◆ Console

‹ Fri · 30 Oct 2026
Standard addition

Early Treatment Trajectory and Long-Term Persistence to Semaglutide for Obesity: A Population-Based Cohort Study.

Most adults stopped semaglutide for obesity within a year, with early discontinuation linked to socioeconomic factors.

This population-based retrospective cohort study examined early treatment trajectory and long-term persistence to semaglutide for obesity: a population-based cohort study. The PubMed abstract reports among 34,309 adults using semaglutide for obesity, discontinuation reached 676% by one year and was associated with socioeconomic and early-treatment factors.

What the study was

Study design
Population-based retrospective cohort study
Population
Adults without diabetes initiating semaglutide for obesity
Sample size
28
Category
Public Health
Maturity
Validated
Journal
Diabetes, obesity & metabolism

Why it surfaced

Score reflects the population-based retrospective cohort study design and relevance to Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; classification is limited to PubMed title, metadata, and abstract evidence.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.